baber/WOPTO huggingface dataset:
Patent AU-2017203604-A1 (AU)
Title: Complex electric fields and static electric fields to effect motion with conduction currents and magnetic materials
Inventor: BANDURIC RICHARD
IPC: H02N11/00
Filed: 2017-05-30
Abstract: In an example, a method includes interacting electric fields from charges in conductors in different inertial reference frames to effect motion. The example method implements the mathematical framework that divides electric fields from charges in different inertial reference frames into separate electric field equations in electrically isolated conductors. The example method may implement the interaction of these electric fields to produce a force on an assembly that can, by way of illustration, propel a spacecraft using electricity without other propellant(s).
Patent AU-2017205694-A1 (AU)
Title: Controlled-release CNP agonists with low NPR-C binding
Inventor: RAU HARALD
IPC: A61P19/00
Filed: 2017-01-05
Abstract: The present invention relates to a controlled-release CNP agonist having low NPR-C affinity; to pharmaceutical compositions comprising said controlled-release CNP agonist; their use; and to methods of treatment.
Patent AU-2017218974-A1 (AU)
Title: Mutant fragments of OspA and methods and uses relating thereto
Inventor: COMSTEDT PAR
IPC: A61K39/02
Filed: 2017-08-22
Abstract: The present invention relates to a polypeptide comprising a mutant fragment of an outer surface protein A (OspA), a nucleic acid coding the same, a pharmaceutical composition 5 (particularly for use as a medicament of in a method of treating or preventing a Borrelia infection) comprising the polypeptide and/or the nucleic acid, a method of treating or preventing a Borrelia infection and a method of immunizing a subject.
Patent AU-2017224994-A1 (AU)
Title: High speed low power digital to analog upconverter
Inventor: NG VINCENT T
IPC: H03M1/74
Filed: 2017-09-04
Abstract: HIGH SPEED LOW POWER DIGITAL TO ANALOG UPCONVERTER Systems and methods according to one or more embodiments are provided for a high speed digital to analog upconverter (101) that provides for converting a plurality of parallel digital data bits (238/239) to an analog output signal (106). In one example, a system (100) includes a decoder circuit (130) configured to receive a plurality of decoder input data bits and provide a plurality of decoded parallel digital data bits. The system (100) also includes a mixer circuit (140) configured to combine each of the decoded parallel digital data bits with a conversion clock signal (145) to provide frequency shifted digital data bits, wherein the frequency shifted digital data bits are time misaligned with each other. The system (100) also includes a synchronizer circuit (105) configured to time align the frequency shifted digital data bits. The system (100) further includes a switching network (102) configured to generate an analog output signal (106) in response to the time aligned frequency shifted digital data bits. (.0 czcc C-.) CIC) >< CD~ N C) ") _C3 (-0 ccz 0-) -i- 0
Patent AU-2017227555-A1 (AU)
Title: Selective catalysts for spinetoram production
Inventor: FOSKEY TAKIYA J
IPC: C07H17/00
Filed: 2017-02-28
Abstract: This invention is based on the discovery that homogeneous catalysts, [Rh(C
Patent AU-2017246455-A1 (AU)
Title: Pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
Inventor: SKERLJ RENATO T
IPC: A61P25/22
Filed: 2017-04-06
Abstract: The invention provides substituted pyrazolo[1,5-a]pyrimidinyl carboxamide and related organic compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat medical disorders, e.g., Gaucher disease, Parkinson's disease, Lewy body disease, dementia, or multiple system atrophy, in a patient. Exemplary substituted pyrazolo[1,5-a]pyrimidinyl carboxamide compounds described herein include 2-heterocyclyl-4-alkyl-pyrazolo[1,5-a]pyrirnidine-3-carboxarnide compounds and variants thereof.
Patent AU-2017251702-A1 (AU)
Title: Use of freeform metadata for access control
Inventor: BRANDWINE ERIC JASON
IPC: G06F7/04
Filed: 2017-10-24
Abstract: Approaches are described for security and access control for computing resources. 5 Various embodiments utilize metadata, e.g., tags that can be applied to one or more computing resources (e.g., virtual machines, host computing devices, applications, databases, etc.) to control access to these and/or other computing resources. In various embodiments, the tags and access control policies described herein can be utilized in a multitenant shared resource environment.
Patent AU-2017253240-A1 (AU)
Title: Compositions and methods for making antibodies based on use of an expression-enhancing locus
Inventor: BABB ROBERT
IPC: C07K16/00
Filed: 2017-04-20
Abstract: This invention relates to site-specific integration and expression of recombinant proteins in eukaryotic cells. In particular, the invention includes compositions and methods for improved expression of antibodies including bispecifc antibodies in eukaryotic cells, particularly Chinese hamster (Cricetulus griseus) cell lines, by employing an expression-enhancing locus.
Patent AU-2017258950-A1 (AU)
Title: Antibody formulations and methods
Inventor: GARIDEL PATRICK
IPC: C12P21/08
Filed: 2017-11-10
Abstract: Abstract Antibody formulations and methods useful for prophylaxis or treatment of amyloidosis, including AA amyloidosis and AL amyloidosis.
Patent AU-2017259981-A1 (AU)
Title: Method and apparatus for deploying and retrieving objects in a cavity
Inventor: EGGERS MITCHELL
IPC: A61B17/00
Filed: 2017-05-03
Abstract: The present invention relates generally to a method and apparatus for deploying and/or retrieving an object (e.g., a vena cava filter) in a cavity (e.g., a vena cava) using a system configured to: (i) maintain grip of the unsheathed object in the cavity until deliberately released, (ii) prevent premature release of the object in the cavity, and/or (iii) facilitate retrieval by first everting said object, then withdrawing the object through a guiding catheter (e.g., retrieval via eversion).
Patent AU-2017277672-A1 (AU)
Title: Apparatuses for releasing a payload from an aerial tether
Inventor: SHANNON TREVOR
IPC: B64D1/02
Filed: 2017-05-22
Abstract: Described herein are apparatuses for passively releasing a payload of an unmanned aerial vehicle (UAV). An example apparatus may include, among other features, (i) a housing; (ii) a swing arm coupled to the housing, wherein the swing arm is operable to toggle between an open position and a closed position; (iii) a spring mechanism adapted to exert a force on the swing arm from the open position toward the closed position; (iv) a receiving system of a UAV adapted to receive the housing, wherein the receiving system causes the swing arm to be arranged in the open position; and (v) a spool operable to unwind and wind a tether coupled to the housing, wherein unwinding the tether causes a descent of the housing from the receiving system, and wherein winding the tether causes an ascent of the housing to the receiving system.
Patent AU-2017278315-A1 (AU)
Title: Settable bone void filler
Inventor: FALLIS ANDREW
IPC: A61K9/14
Filed: 2017-06-12
Abstract: The invention provides composite materials that form a biocompatible and bioresorbable settable ceramic-forming composition, and that possesses high strength when set and other desirable mechanical properties. The composite materials may include additive materials that provide beneficial advantages in the handling and physical properties of the material. When a hydrated precursor, the composite material is capable of being injected through cannulas for placement in treatment sites. The composite material provided desirable handling properties and sets in a clinically relevant time period.
Patent WO-2018195600-A1 (WO)
Inventor: SANKARIDURG PADMAJA
IPC: G02C7/00
Filed: 2018-04-27
Abstract: An ophthalmic lens system for reducing the risk of progression of a myopic eye by selectively maintaining, inducing or creating asymmetry of the peripheral retinal profile for the eye. A method for reducing the risk of progression of myopia comprising determining the magnitude of asymmetry of the on-axis/off-axis refractive error profile or eye length profile of the eye and providing an ophthalmic lens system that corrects for and provides acceptable on-axis vision and simultaneously controls the position of the off-axis refractive error profile or eye length profile such that resultant profile of the eye is asymmetric.
Patent WO-2019071307-A1 (WO)
Title: Electronic lockset
Inventor: SULLIVAN KEVIN
IPC: G07C9/00
Filed: 2018-10-10
Abstract: This invention relates to an electronic lockset (1) to control movement of a bolt (5) by rotation of either an outer hand operable member (8) or an inner hand operable member (7). The electronic lockset (1) includes an outer coupling (19) and an inner coupling (20) which are each adjustable between an engaged condition and a disengaged condition to render each of the inner hand operable member (7) and an outer hand operable member (8) operable or inoperable respectively. The electronic lockset (1) also includes an outer user interface (9) which can receive user credentials to adjust at least a condition of the inner coupling (20) from the engaged condition to the disengaged condition.
Patent WO-2019075527-A1 (WO)
Title: Method to improve crop yields
Inventor: ROWLEY ALLAN JAMES
IPC: A01N47/04
Filed: 2018-10-19
Abstract: A method of improving crop yields particularly in respect of crops from the Poaceae family, the method comprising applying a composition having an effective amount of mefluidide as a component thereof to the crop, the application being made at or about the pre flowering stage of the crop.
Patent AU-2018200312-A1 (AU)
Title: Detection and treatment of fibrosis
Inventor: AGARWAL SANDEEP K
IPC: G01N33/48
Filed: 2018-01-14
Abstract: Methods of treating a subject having fibrosis or at risk of developing fibrosis by administering a Cadherin- 11 (CD-H 11) antagonist are provided. The treatment may be administered to subjects with dermal or non-dermal fibrosis, including lung, liver or kidney fibrosis or idiopathic pulmonary fibrosis. Methods of assessing the levels of CDH1 1 in a subject and determining fibrosis or risk of developing fibrosis are also provided.
Patent AU-2018200360-A1 (AU)
Title: Bit allocating, audio encoding and decoding
Inventor: KIM MI YOUNG
IPC: G10L19/02
Filed: 2018-01-16
Abstract: A bit allocating method is provided that includes determining the allocated number of bits in decimal point units based on each frequency band so that a Signal-to-Noise Ratio (SNR) of a spectrum existing in a predetermined frequency band is maximized within a range of the allowable number of bits for a given frame; and adjusting the allocated number of bits based on each frequency band.
Patent AU-2018203274-A1 (AU)
Title: Training an RGB-D classifier with only depth data and privileged information
Inventor: PENG KUAN-CHUAN
IPC: G06T1/40
Filed: 2018-05-11
Abstract: TRAINING AN RGB-D CLASSIFIER WITH ONLY DEPTH DATA AND PRIVILEGED INFORMATION Embodiments of the present invention provide a computer-implemented method for training an RGB-D classifier for a scene classification task. The method receives task-relevant labeled depth data, task-irrelevant RGB-D data, and a given trained representation in RGB. The method simulates an RGB representation using only the task-irrelevant RGB-D data. The method builds a joint neural network using only the task-irrelevant RGB-D data and the task relevant labeled depth data.
Patent AU-2018203807-A1 (AU)
Title: Surgical access system
Inventor: MARK JOSEPH L
IPC: A61B5/00
Filed: 2018-05-30
Abstract: A surgical access assembly is disclosed. The surgical access assembly comprises an outer sheath defined by an open distal end and an open proximal end and including a hollow body portion therebetween; an obturator defined by a distal end and a proximal end, a body portion therebetween, and has a central channel formed within the body portion, wherein the distal end further comprises a tapered distal tip member that terminates in a closed radiused distal tip; a navigational probe, wherein the navigational probe is selectively seated within the central channel; andwherein the obturator is configured to be received within the outer sheath such that the tapered distal tip member protrudes from the open distal end of the outer sheath when the obturator is in an introducing configuration.
Patent AU-2018203937-A1 (AU)
Title: Gall wasp control method
Inventor: LYONS GLENN
IPC: A01G13/00
Filed: 2018-06-04
Abstract: - 13 A method of controlling gall wasp infestation in a tree is disclosed. The method comprising applying a barrier coating to a gall prior to emergence of the gall wasps 5 where the barrier coating is effective to prevent emergence of at least some of the wasps. Also disclosed is a liquid latex that can be applied to a tree. The liquid latex includes an effective amount of insecticide for killing gall wasps 10152571_1 (GHMatters) P105933.AU 4/06/18 Figure 1 Figure 2 10152571_1 (GHMatters) P105933.AU 4/06/18
Patent AU-2018213976-A1 (AU)
Title: Portable electronic device
Inventor: JARVIS DANIEL W
IPC: H04M99/00
Filed: 2018-08-06
Abstract: Portable electronic devices having I/O assemblies that can include optical and audio components are described. An exemplary I/O assembly can include a first 5 camera module and a second camera module that can be carried within a camera module housing. A flex connector can carry a strobe that can be positioned between the first camera module and the second camera module. A trim can enclose the first camera, the second camera and the strobe and optically isolates the optical components. An exemplary portable electronic device can include a side wall retainer 10 that defines its perimeter, a front cover glass and a rear cover glass that cooperate to form an enclosure. The I/O assembly can be secured to the enclosure both from inside and outside of the rear cover glass. /O assembly can also include an audio transducer that can record sound when the camera module are recording videos. N, 514 N, 504 508 502 N, (-l 512 504 502 508 506 516 512 516 506 510 502 504 522- 524 522 518- -/518
Patent AU-2018231083-A1 (AU)
Title: Head-mounted light field display with integral imaging and waveguide prism
Inventor: HUA HONG
IPC: G02F1/29
Filed: 2018-03-06
Abstract: Freeform waveguide prism and use with head-mounted light field display with integral imaging and relay group.
Patent AU-2018234479-A1 (AU)
Title: 2-aminoimidazole-phenyl derivatives useful for controlling microbial growth
Inventor: MELANDER CHRISTIAN
IPC: A01N43/50
Filed: 2018-03-08
Abstract: Provided are 2-aminoimidazole-phenyl derivative compounds of Formula (I): which compounds are useful in methods of controlling microbial growth, such as by enhancing the effects of an antibiotic administered in combination with the compound. Compositions including these compounds, devices including these compounds, and methods of using the same are also provided.
Patent AU-2018239239-A1 (AU)
Title: Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use
Inventor: BAZAN NICOLAS G
IPC: C07C59/42
Filed: 2018-03-19
Abstract: Provided are compounds, pharmaceutical compositions, cosmetic and dermatological compositions or nutritional supplement compositions, comprising omega-3 very-long-chain polyunsaturated fatty acids (n-3 VLC-PUFAs) and/or their endogenous hydroxylated derivatives thereof, known as elovanoids. This disclosure provides methods for neuroprotection, organ and tissue protection or restoration, prevention or slowing down of aging-related diseases and conditions, and sustainment of function during the aging process.
Patent AU-2018240839-A1 (AU)
Title: Apparatus and method for making a stereolithographic object
Inventor: ELSEY JUSTIN
IPC: B29C64/00
Filed: 2018-03-20
Abstract: An object can be made one section at a time, that is layerwise, using an apparatus for making an object using a stereolithographic method. In a step of the stereolithographic method, a layer of a material used for making the object may be solidified in the shape of a section of the object. "! Disclosed herein is an apparatus (100) for making a stereolithographic object (122). Also disclosed herein is a method for making a stereolithographic object (122).
Patent AU-2018252191-A1 (AU)
Title: Antisense oligonucleotides for the treatment of stargardt disease
Inventor: YILMAZ-ELIS ALIYE SEDA
IPC: C12N15/11
Filed: 2018-04-13
Abstract: The invention relates to the fields of medicine and biotechnology. In particular, it relates to novel antisense oligonucleotides (AONs) that may be used in the treatment, prevention and/or delay of Stargardt disease and/or ABCA4-associated eye disease. More in particular, the invention relates to AONs that are used in inhibiting or blocking exon 39 skipping in the human ABCA4 pre-mRNA.
Patent AU-2018253463-A1 (AU)
Title: Conjugates of an IL-2 moiety and a polymer
Inventor: BOSSARD MARY J
IPC: C07K1/00
Filed: 2018-10-23
Abstract: Abstract Conjugates of an IL-2 moiety and one or more nonpeptidic, water-soluble polymers are provided. Typically, the nonpeptidic, water-soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided, among other things, are compositions comprising conjugates, methods of making conjugates, methods of administering compositions to an individual, nucleic acid sequences, expression systems, host cells, and methods for preparing IL-moieties.
Patent AU-2018256897-A1 (AU)
Title: Methods and systems for redox flow battery electrolyte hydration
Inventor: SONG YANG
IPC: H01M8/04298
Filed: 2018-04-27
Abstract: Methods and systems are provided for transporting and hydrating a redox flow battery system with a portable field hydration system. In one example, the redox flow battery system may be hydrated with the portable field hydration system in a dry state, in the absence of liquids. In this way, a redox flow battery system may be assembled and transported from a battery manufacturing facility to an end-use location off-site while the redox flow battery system is in the dry state, thereby reducing shipping costs, design complexities, as well as logistical and environmental concerns.
Patent AU-2018276134-A1 (AU)
Title: Active crystallisation control in phase change material thermal storage systems
Inventor: BISSELL ANDREW JOHN
IPC: F28D20/02
Filed: 2018-05-31
Abstract: The present invention relates to phase-change materials (PCM) which store and release thermal energy by undergoing melt/crystallisation cycles. More particularly, there is described a thermal storage system where sub-cooled phase change material (PCM) is nucleated via a controlled thermal region(s).
Patent AU-2018282339-A1 (AU)
Title: Concentrated suspension of agrochemicals in high electrolyte aqueous medium
Inventor: ZHU SHAWN
IPC: C05G3/80
Filed: 2018-12-19
Abstract: The present invention generally relates to stable suspension concentrates (SC) displaying shear thinning property and comprising: a water soluble salt, an electrolyte water thickening polymer (e.g., xanthan gum or guar gum), an insoluble solid agrochemical and water. The 5 water soluble salt can be an inorganic salt or a pesticide salt (e.g. fertilizer or water soluble herbicide such as glyphosate, glufosinate, dicamba, MCPA or 2,4-D); the water thickening polymer is a water soluble polymer capable of fully hydrating and thickening the salt solution (e.g. AGHRO DR-2000); and the insoluble solid agrochemical can be a cellulosic derivative MEHEC, a water insoluble pesticide (e.g. atrazine, clothianidin or imidacloprid), a water 0 insoluble growth regulator, a water insoluble micronutrient or mixtures thereof. The invention further relates to a method of producing said suspension comprising dissolving thickening polymer in water, adding water soluble salt and adding water insoluble agrochemical.
Patent AU-2018287728-A1 (AU)
Title: Hydrogenation process for preparing oxycodone hydrochloride from 14-hydroxycodeinone
Inventor: GAUVREAU PAUL
IPC: C07D489/08
Filed: 2018-06-12
Abstract: A process for preparing oxycodone hydrochloride, said process comprising hydrogenating 14- hydroxycodeinone in an alcoholic solvent and hydrochloric acid to form oxycodone hydrochloride, wherein (a) the hydrogenation is carried out in the presence of a heterogeneous platinum group metal (PGM) catalyst and hydrogen gas, (b) the hydrogenation is carried out at one or more temperatures greater than ambient temperature in the presence of a hydrogenation catalyst and hydrogen gas, wherein the solution of 14- hydroxycodeinone and hydrochloric acid is heated to temperature before it is exposed to the hydrogen gas, (c) the oxycodone hydrochloride comprises 6a-oxycodol in an amount < about 0.300 area % as determined by HPLC, characterized in that (d) the pH of the solution of 14-hydroxycodeinone and hydrochloric acid is in the range of about ≥ 2.5 to about ≤ 4.5; (e) the process is carried out in one pot, and (f) the oxycodone hydrochloride precipitates out of the solution.
Patent AU-2018306521-A1 (AU)
Title: Detecting service provider state based on received and historic telematics data and service provider characteristics
Inventor: O'Herlihy Michael
IPC: H04L29/08
Filed: 2018-07-09
Abstract: A network system is configured to facilitate a safe service coordination environment. The network system detects abnormal user states (e.g., sleepiness, inebriation, etc.) and provides corrective recommendations to those users. To do so, client devices executing an application send information associated with the service to the network system. The network system determines an aggregate set of service characteristics based on the aggregate telematics data. The network system also determines a provider profile for a provider providing service in the environment describing the deviation of the user's driving characteristics from the aggregate service characteristics. Based on the difference between the aggregate characteristics and the user profile, the network system determines the provider state using a state verification process. Based on the determined provider state, the network system determines a set of corrective recommendations and sends the corrective recommendations to the provider device.
Patent AU-2018323875-A1 (AU)
Title: Methods for preparing therapeutically active cells using microfluidics
Inventor: WARD ANTHONY
IPC: A61P35/00
Filed: 2018-08-22
Abstract: The present invention is directed to the use of microfluidics in the preparation of cells and compositions for therapeutic uses. In its first aspect, the invention is directed to a method of genetically engineering a population of target cells. This is done by isolating the target cells from a crude fluid composition by performing Deterministic Lateral Displacement (DLD) on a microfluidic device. The invention includes a method of producing CAR T cells by obtaining a crude fluid composition comprising T cells and performing DLD on the composition using a microfluidic device. In another aspect, the invention is directed to a method of treating a patient for cancer, an autoimmune disease or an infectious disease by administering CAR T cells engineered according to the method.